BD Increases Dividend for 53rd Year in a Row
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $1.04 per common share, which represents a notable 9.5% increase from the prior quarter. This increase reflects the company's ongoing commitment to delivering value to its shareholders and underscores its strong financial performance.
Reflection of Confidence in Future Growth
As the company continues to uphold its proud tradition of dividend growth, it marks the 53rd consecutive year of raising dividends. This accomplishment maintains BD’s presence among the elite S&P 500 Dividend Aristocrats Index, which includes companies that have consistently increased their dividends for a minimum of 25 consecutive years. Tom Polen, the chairman, CEO, and president of BD, states, "This increase reflects our confidence in our long-term outlook as well as our commitment to delivering value through our BD 2025 strategy. We are focused on returning capital to our shareholders while advancing our business operations."
About Becton, Dickinson and Company
BD stands out as one of the largest global medical technology companies, committed to improving health care through its innovative technology and services. The company plays a vital role in supporting healthcare professionals worldwide by providing cutting-edge solutions aimed at enhancing clinical efficiency and patient care. With a dedicated workforce exceeding 70,000 employees, BD's focus is on addressing global health challenges through strategic partnerships and collaboration.
Commitment to Quality and Safety
BD continues to innovate in the medical sector by providing tools that improve the safety and efficiency of healthcare delivery. Its products help laboratory scientists accurately diagnose diseases and empower research professionals to develop the next generation of diagnostics and therapeutics. Such efforts ensure that BD remains at the forefront of enhancing patient outcomes while keeping healthcare costs manageable and processes efficient. To learn more about BD's initiatives and innovations, visit bd.com or connect on LinkedIn and social media platforms.
Investor Relations Contact Information
BD is committed to transparency and open communication with its investors. For inquiries related to media or investor relations, interested parties can reach out to:
Media Contacts
Troy Kirkpatrick
VP, Public Relations
858.617.2361
Investor Contacts
Adam Reiffe
Sr. Director, Investor Relations
201.847.6927
Frequently Asked Questions
What is the significance of the dividend increase by BD?
The dividend increase reflects BD's strong financial health and its commitment to returning value to shareholders while maintaining growth.
How long has BD been increasing its dividends?
BD has successfully raised its dividend for 53 consecutive years, showcasing its stability and commitment to its shareholders.
What is the new quarterly dividend amount for BD?
The new quarterly dividend is set at $1.04 per common share, representing a 9.5% increase from the previous quarter.
How does BD support its healthcare professionals?
BD provides innovative technology, services, and solutions aimed at enhancing clinical efficiency and the overall delivery of care.
Where can I find more information about BD's products and services?
More information can be found on BD's official website at bd.com, where the company outlines its various initiatives and product offerings.
